Several factors contribute to these elevated costs: Patent protection Most GLP-1 medications are still under patent, preventing generic competition Manufacturing complexity These are biologic medications that require specialized production processes Research and development costs Pharmaceutical companies invest heavily in clinical trials and regulatory approval Market positioning These medications are often priced as premium treatments Without insurance coverage, patients face the full retail price, which can make these medications financially inaccessible for many people who need them
Retrieved from Elahi Vahed, I., Shahir-Roudi, E., Nojumi, S., et al
47 states Feel better
Managing Weight Loss Safely With Existing Gallbladder Issues If you have gallbladder disease and want to lose weight with semaglutide, several strategies reduce biliary risk
gastroparesis, a disorder that slows or stops the movement of food from the stomach to the intestines
For people with recent-onset type 2 diabetes, bariatric surgery may be considered at a lower BMI threshold of 30-34.9 kg/m
